中文
EN
About us
Company Introduction
Corporate History
Business Introduction
Corporate Governance
Company Culture
Corporate Honors
R&D and Innovation
R&D
Innovation
Product Pipeline
Achievements
Products
Drug Products
Biological products
APIs
Intermediates
Boranes
OLED Materials
CDMO
Project Collaboration
In-/Out-Licensing
Joint Venture
Sustainable
EHS
Energy
Quality
Supplier
News Center
2024
2023
2022
2021
Join Us
Talent Philosophy
Talent Development
Salary and Benefits
Campus Recruiting
Social Recruitment
Contact Us
Online Message
Blog Center
In 2024
In 2023
In 2022
In 2021
In 2020
In 2019
In 2018
In 2017
In 2016
Viwit Pharmaceutical's Phenylephrine Hydrochloride Injection Officially Receives Official Approval by China NMPA
Viwit Pharmaceuticals’ Brimonidine tartrate and Timolol maleate eye drops receive Official Approval by China NMPA
Viwit's Nitroglycerin Sublingual Tablets Approved by FDA
Viwit Pharmaceuticals API Site Successfully Passed FDA cGMP On-site Audit with "No Action Indicated"
Viwit Pharmaceutical Co. Ltd. announces exclusive licensing and supply agreement for two Gadolinium based Magnetic Resonance Imaging (MRI) injectable contrast agents in the US.
Viwit Pharmaceutical’s Lifitegrast API has completed registrations in both China and the US!
Mr. Wei attended and exchanged keynote speeches on talent cooperation and entrepreneurship in Shandong (East US)
On the evening of April 26, New York time, Dr. Wei Yanjun, Chairman and President of Viwit, delivered a keynote speech at the Shandong (East US) Talents Cooperation and Entrepreneurship Exchange.
27
2016
/
04
Viwit 2016 Annual Gala Successfully Held
On January 24th, all employees of Viwit held the 2016 Spring Festival in the blue brick and red tile Longyuan Ancient Town. The company's president Wei Yanjun gave a congratulatory message to all employees, affirmed the work in 2015, thanked all the wise people for their hard work over the past year, expressed their expectations for future development, and sent the deepest to all employees and their families. blessing.
24
01
Congratulations to Viwit Pharmaceutical Co.,Ltd for passing Cofepris certification of the Ministry of Health of Mexico
In October 2015, Viwit Pharmaceutic Co., Ltd. ushered in the GMP audit of the Atazanavir Sulfate API by the Mexican official Cofepris. After five days of intensive and orderly inspection and certification, we have all zero defects It successfully passed the on-site inspection and finally obtained the GMP certificate issued by the Mexican Ministry of Health Cofepris. The Cofepris certification of the Mexican Ministry of Health further strengthened the company's GMP concept and improved the production management system. At the same time, it opened the door to the Latin American market for the company's sales of APIs and became the cornerstone of future regulatory market certification.
2015
10
Search